Tegrase inhibitors disrupt core maturation and induce a reverse transcription block
Tegrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells. PLoS ONE. 2013;8:e74163. 10. Fenwick C, Amad M, Bailey MD, Bethell R, B M, Bonneau P, et al. Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor. Antimicrob Agents Chemother. 2014;58:3233?4. 11. Sharma A, Slaughter A, Jena N, Feng L, Kessl JJ, Fadel HJ, et al. A new class of multimerization selective inhibitors of HIV-1 integrase. PLoS Pathog. 2014;10:e1004171. 12. Le Rouzic E, Bonnard D, Chasset S, Bruneau J-M, Chevreuil F, Le Strat F, et al. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage. Retrovirology. 2013;10:144. 13. Christ F, Shaw S, Demeulemeester J, Desimmie BA, Marchand A, Butler S, et al. Small-molecule inhibitors of the LEDGF/p75 binding site of24.25. 26.27. 28. 29. 30.31. 32.33.34.integrase block HIV replication and modulate integrase multimerization. Antimicrob Agents Chemother. 2012;56:4365?4. Desimmie BA, Schrijvers R, Demeulemeester J, Borrenberghs D, Weydert C, Thys W, et al. LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions. Retrovirology. 2013;10:57. Jurado KA, Wang H, Slaughter A, Feng L, Kessl JJ, Koh Y, et al. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation. Proc Natl Acad Sci USA. 2013;110:8690?. Fontana J, Jurado KA, Cheng N, Ly NL, Fuchs JR, Gorelick RJ, et al. Distribution and redistribution of HIV-1 nucleocapsid protein in immature, mature, PD173074 chemical information pubmed ID:https://www.ncbi.nlm.nih.gov/pubmed/28854080 and integrase-inhibited virions: a role for integrase in maturation. J Virol. 2015;89:9765?0. Kessl JJ, Kutluay SB, Townsend D, Rebensburg S, Slaughter A, Larue RC, et al. HIV-1 integrase binds the viral RNA genome and is essential during virion morphogenesis. Cell. 2016;166(1257?268):e12. Vranckx LS, Demeulemeester J, Saleh S, Boll A, Vansant G, Schrijvers R, et al. LEDGIN-mediated inhibition of Integrase EDGF/p75 interaction reduces reactivation of residual latent HIV. EBioMedicine. 2016;8:248?4. Girard MP, Osmanov S, Assossou OM, Kieny M-P. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review. Vaccine. 2011;29:6191?18. Garcia F, Routy J-P. Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection. Vaccine. 2011;29:6454?3. Garcia F, Climent N, Guardo AC, Gil C, Leon A, Autran B, et al. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication. Sci Transl Med. 2013;5:166ra2. Chasset S, Chevreuil F, Ledoussal B, PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/26437915 Le Strat F, Benarous R. Inhibitors of viral replication, their process of preparation and their therapeutical uses. WO2014/053666A1. 2014. van Bel N, van der Velden Y, Bonnard D, Le Rouzic E, Das AT, Benarous R, et al. The allosteric HIV-1 Integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome. PLoS ONE. 2014;9:e103552. Rutebemberwa A, Bess JW, Brown B, Arroyo M, Eller M, Slike B, et al. Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses. AIDS Res Hum Retroviruses. 2007;23:532?2. Kodama T, Wooley DP, Naidu YM, Kestler HW, Daniel MD, Li Y, et al. Significance of premature stop codons in env of simian immunodeficiency virus. J Virol. 1989;63:4709?4. Moog C, Dereuddre-Bosquet N, Teillaud J-L, Biedma ME, Holl V, Van Ham G, et al.